Benzinga | May 13, 2021 04:49PM EDT

AbCellera Biologics Q1 EPS $0.37 Misses $0.38 Estimate, Sales $203.00M Beat $196.48M Estimate

AbCellera Biologics (NASDAQ:ABCL) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.38 by 2.63 percent. The company reported quarterly sales of $203.00 million which beat the analyst consensus estimate of $196.48 million by 3.32 percent.